Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

832
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
832
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

6.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Thliphthisasapphus</i> (Rubiaceae, Rubieae), a new species from Lefkada (Ionian Islands, Greece) and its ecological position.

PhytoKeys·2024
Same author

Nurse awareness of patients who may have incident delirium.

Nursing older people·2017
Same author

Dabigatran versus warfarin in patients with atrial fibrillation.

Nursing older people·2017
Same author

Use of probiotics for infection prevention in trauma patients.

Nursing older people·2017
Same author

Benefits of dark chocolate in treating metabolic syndrome.

Nursing older people·2016
Same author

Flexibility and choice improved residents' feeling of wellbeing.

Nursing older people·2016

Related Experiment Video

Updated: Mar 13, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Clostridium difficile infection.

Ruth Sander1

  • 1The University of Portsmouth.

Nursing Older People
|October 16, 2016
PubMed
Summary
This summary is machine-generated.

Clostridium difficile (C. diff) is present in healthy adults but causes illness when antibiotics disrupt gut flora. This infection can lead to mild diarrhea or severe conditions like toxic megacolon.

More Related Videos

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.3K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.4K

Related Experiment Videos

Last Updated: Mar 13, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.3K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.4K

Area of Science:

  • Microbiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Clostridium difficile (C. diff) is a common bacterium found in the gut flora of healthy individuals.
  • Disruption of normal gut microbiota, often due to antibiotic use, can lead to C. diff proliferation.
  • C. diff infection (CDI) is a significant cause of antibiotic-associated diarrhea and colitis.

Purpose of the Study:

  • To describe the clinical spectrum of Clostridium difficile infections.
  • To highlight the association between antibiotic exposure and the development of CDI.
  • To identify risk factors and clinical presentations indicative of severe C. diff disease.

Main Methods:

  • Review of clinical cases and literature on Clostridium difficile infections.
  • Analysis of patient data to correlate symptoms with disease severity.
  • Microbiological culture and identification of C. diff from stool samples.

Main Results:

  • Clostridium difficile can be cultured from 3% of healthy adults, who are typically asymptomatic.
  • Antibiotic-induced disruption of gut flora is a primary factor in the development of symptomatic CDI.
  • Clinical manifestations range from mild diarrhea to severe, life-threatening conditions such as fulminant colitis and toxic megacolon.
  • A subset of 'silent' infections may present with abdominal pain and distension without significant diarrhea, potentially indicating severe disease.

Conclusions:

  • Clostridium difficile remains a common commensal but can cause significant gastrointestinal illness upon disruption of the host's microbiota.
  • Early recognition of symptoms, including atypical presentations like abdominal pain and distension, is crucial for diagnosing severe CDI.
  • Understanding the pathogenesis and clinical spectrum of CDI is essential for effective patient management and treatment strategies.